Other nominees for this significant honour included the George Institute for Global Health, Rare Cancers Australia, Red Cross Blood Service, HammonCare, Change Sky, Barbara May Foundation, GPs Down Under (GPDU), and the Australasian Health Alliance.
“I believe our best work lies ahead, as we prepare to announce the successful candidate of the Lawrence Penn Chair in Bowel Cancer Research and the leading edge research focus,” said Bowel Cancer Australia CEO Julien Wiggins, following his acceptance of the award on behalf of the 100% community-funded charity’s contribution to making real change happen across the entire continuum of care.
“In addition, we will soon implement a patient-led outcomes measurement program which will truly transform healthcare for bowel cancer patients, by prioritising what matters most to them,” Mr Wiggins said.
The Award highlights the big impact Bowel Cancer Australia is making, despite the organisation’s small size and limited budget when compared with comparable cancer charities.
It also serves as recognition of the collective effort – past and present – of staff and colleagues, fundraisers and donors, patients and volunteers, who have all helped contribute to Bowel Cancer Australia’s success over the years.
Founded in 2000, Bowel Cancer Australia has become the leading bowel cancer charity, through initiatives such as Bowel Cancer Awareness Month, BowelScreen Australia – a pharmacy-based screening program, and the Big Bowel Tour.
Bowel Cancer Australia offers the only Bowel Care Nurse Helpline and a highly popular Peer-to-Peer Support Network, often referred to by patients and loved ones as a ‘lifeline’.
In addition, the charity provides an unrivalled suite of patient information, publications and resources – including the highest-ranking bowel cancer website in the country, an active online community of over 108,000 followers and the world’s first bowel cancer app.
This is the third time Bowel Cancer Australia has been recognised by PRIME for excellence.
The first win came in 2014, when Bowel Cancer Australia received the Corporate Social Responsibility Award along with Bayer Australia for the My Cancer My Voice campaign.
In 2016, Bowel Cancer Australia and Princeton Digital were honoured for Excellence in Patient/Customer Support, following the release of the world’s first Bowel Cancer mobile app.
“This recognition as NGO of the Year is testament to the consistently high standard of work and services provided by Bowel Cancer Australia and to the sincere commitment to championing what matters most to people affected by bowel cancer, across the care continuum,” said Mr Wiggins.